| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1030029821 |
| P356 | DOI | 10.1186/1744-8069-8-34 |
| P932 | PMC publication ID | 3460752 |
| P698 | PubMed publication ID | 22540262 |
| P5875 | ResearchGate publication ID | 224861277 |
| P2093 | author name string | Joyce A DeLeo | |
| Edgar Alfonso Romero-Sandoval | |||
| Christian Ndong | |||
| Russell P Landry | |||
| P2860 | cites work | JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain | Q37194288 |
| Evidence for the role of proteoglycans in cation-mediated gene transfer | Q37236667 | ||
| Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation | Q37246426 | ||
| Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain | Q39323926 | ||
| Spinal injection of TNF-α-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1 | Q42150441 | ||
| Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres | Q44258496 | ||
| p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. | Q44451943 | ||
| Spinal blockade of TNF blocks spinal nerve ligation-induced increases in spinal P-p38. | Q44751504 | ||
| Systemic delivery of DNA or siRNA mediated by linear polyethylenimine (L-PEI) does not induce an inflammatory response | Q44986711 | ||
| Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization. | Q45072859 | ||
| Spinal p38beta isoform mediates tissue injury-induced hyperalgesia and spinal sensitization | Q45301986 | ||
| Repeated intrathecal administration of plasmid DNA complexed with polyethylene glycol-grafted polyethylenimine led to prolonged transgene expression in the spinal cord | Q45863310 | ||
| Efficient transfection method for primary cells | Q45886253 | ||
| Brain-derived neurotrophic factor enhances the excitability of rat sensory neurons through activation of the p75 neurotrophin receptor and the sphingomyelin pathway | Q46616468 | ||
| The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells | Q46875092 | ||
| Polyethylenimine-mediated NGF gene delivery protects transected septal cholinergic neurons | Q47598961 | ||
| RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts | Q48472950 | ||
| Attenuation of the acute inflammatory response by dual specificity phosphatase 1 by inhibition of p38 MAP kinase. | Q54359086 | ||
| Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury. | Q54589616 | ||
| Activation of p38 mitogen-activated protein kinase in spinal microglia contributes to incision-induced mechanical allodynia. | Q54778599 | ||
| Polyethylenimine-mediated DNA transfection of peripheral and central neurons in primary culture: probing Ca2+ channel structure and function with antisense oligonucleotides | Q71309191 | ||
| Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain | Q73605805 | ||
| Novel p38α mitogen-activated protein kinase inhibitor shows analgesic efficacy in acute postsurgical dental pain | Q84323026 | ||
| Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation | Q22011000 | ||
| Evidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative pain | Q27325738 | ||
| Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1 | Q28208304 | ||
| Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia | Q28571667 | ||
| Quantitative assessment of tactile allodynia in the rat paw | Q29617366 | ||
| MAP kinase and pain | Q30482277 | ||
| Low molecular weight polyethylenimines linked by beta-cyclodextrin for gene transfer into the nervous system | Q31034767 | ||
| Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system | Q31984627 | ||
| Cationic glycopolymers for the delivery of pDNA to human dermal fibroblasts and rat mesenchymal stem cells | Q33897526 | ||
| Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations | Q33973992 | ||
| The evidence for pharmacological treatment of neuropathic pain | Q34130946 | ||
| RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo | Q34379366 | ||
| Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision | Q34616582 | ||
| Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. | Q34624894 | ||
| p38 MAPK, microglial signaling, and neuropathic pain | Q36345136 | ||
| Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administration | Q36642679 | ||
| Efficacy of nonviral gene transfer in the canine brain | Q36658314 | ||
| Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord | Q36691900 | ||
| A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine | Q36833845 | ||
| Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury | Q37108580 | ||
| P921 | main subject | neuropathic pain | Q2798704 |
| P304 | page(s) | 34 | |
| P577 | publication date | 2012-04-27 | |
| P1433 | published in | Molecular Pain | Q15766244 |
| P1476 | title | Mitogen activated protein kinase phosphatase-1 prevents the development of tactile sensitivity in a rodent model of neuropathic pain | |
| P478 | volume | 8 |
| Q37721461 | A novel p38 MAPK docking-groove-targeted compound is a potent inhibitor of inflammatory hyperalgesia. |
| Q41815861 | A role for mitogen-activated protein kinase phosphatase 1 (MKP1) in neural cell development and survival. |
| Q38727831 | Current and Future Issues in the Development of Spinal Agents for the Management of Pain |
| Q64250777 | Dual-Specificity Phosphatase Regulation in Neurons and Glial Cells |
| Q33933720 | Epigenetic modification of DRG neuronal gene expression subsequent to nerve injury: etiological contribution to complex regional pain syndromes (Part II) |
| Q34404534 | Genomewide analysis of rat periaqueductal gray-dorsal horn reveals time-, region- and frequency-specific mRNA expression changes in response to electroacupuncture stimulation |
| Q37381399 | Glia and pain: is chronic pain a gliopathy? |
| Q35058471 | Lost but making progress--Where will new analgesic drugs come from? |
| Q38763122 | Macrophage-specific nanotechnology-driven CD163 overexpression in human macrophages results in an M2 phenotype under inflammatory conditions. |
| Q38222568 | Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 in Nervous System Development and Disease |
| Q37735788 | Mitogen-activated protein kinase phosphatase-3 (MKP-3) in the surgical wound is necessary for the resolution of postoperative pain in mice. |
| Q33925526 | Neuropathic pain promotes adaptive changes in gene expression in brain networks involved in stress and depression |
| Q33925677 | Pathological pain and the neuroimmune interface |
| Q36223310 | Spinal cannabinoid receptor type 2 agonist reduces mechanical allodynia and induces mitogen-activated protein kinase phosphatases in a rat model of neuropathic pain |
| Q28300818 | Spinal mitogen-activated protein kinase phosphatase-3 (MKP-3) is necessary for the normal resolution of mechanical allodynia in a mouse model of acute postoperative pain |
| Q38019775 | The role of the immune system in the generation of neuropathic pain |
| Q24288817 | The search for novel analgesics: targets and mechanisms |
Search more.